Literature DB >> 26774014

Basal insulin intensification in type 2 diabetes: a key role for GLP-1 receptor agonists.

Pr Bernard Charbonnel1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26774014     DOI: 10.1016/S1262-3636(16)30001-5

Source DB:  PubMed          Journal:  Diabetes Metab        ISSN: 1262-3636            Impact factor:   6.041


× No keyword cloud information.
  2 in total

Review 1.  A Review of Basal-Bolus Therapy Using Insulin Glargine and Insulin Lispro in the Management of Diabetes Mellitus.

Authors:  Riccardo Candido; Kathleen Wyne; Ester Romoli
Journal:  Diabetes Ther       Date:  2018-04-13       Impact factor: 2.945

2.  Risk of clinically relevant hypoglycaemia in patients with type 2 diabetes self-titrating insulin glargine U-100.

Authors:  Priscilla A Hollander; Jacek Kiljanski; Erik Spaepen; Cynthia J Harris
Journal:  Diabetes Obes Metab       Date:  2019-08-01       Impact factor: 6.577

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.